Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

GERN
Geron Corp
stock NASDAQ

Market Open
May 19, 2025 1:00:04 PM EDT
1.36USD+6.693%(+0.09)9,408,047
1.35Bid   1.36Ask   0.01Spread
Pre-market
May 19, 2025 8:43:30 AM EDT
1.26USD-0.787%(-0.01)6,951
After-hours
May 16, 2025 4:24:30 PM EDT
1.27USD-0.781%(-0.01)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 21, 2022
07:30AM EST  Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference   Business Wire
Jan 20, 2022
04:30PM EST  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Jan 4, 2022
05:01PM EST  Geron to Present at the H.C. Wainwright BioConnect Conference   Business Wire
Dec 16, 2021
04:30PM EST  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Dec 14, 2021
04:30PM EST  Geron Reports Presentations at American Society of Hematology Annual Meeting   Business Wire
Dec 2, 2021
07:33AM EST  Geron Appoints Edward Koval As EVP And Chief Business Officer   RTTNews
07:30AM EST  Geron Announces Appointment of Chief Business Officer   Business Wire
Nov 18, 2021
04:30PM EST  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Nov 12, 2021
07:30AM EST  Geron to Present at the Stifel 2021 Virtual Healthcare Conference   Business Wire
Nov 9, 2021
06:00PM EST  Geron Presents Investor Event Highlights   Business Wire
Nov 4, 2021
09:12AM EDT  Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting   Business Wire
Nov 2, 2021
11:11AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021   Benzinga
10:42AM EDT  Baird Initiates Coverage On Geron with Outperform Rating, Announces Price Target of $4   Benzinga
Oct 25, 2021
04:33PM EDT  Geron Says Enters Into New Innovative Licensing And Access Pathway In U.K. For Imetelstat   Benzinga
04:30PM EDT  Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat   Business Wire
Oct 21, 2021
04:30PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Oct 18, 2021
07:36AM EDT  Geron Completes Patient Enrollment In IMerge Phase 3 Trial In Lower Risk Myelodysplastic Syndromes   RTTNews
07:32AM EDT  Geron Announces Completion Of Patient Enrollment In IMerge Phase 3 Clinical Trial In Lower Risk Myelodysplastic Syndromes   Benzinga
Oct 15, 2021
04:05PM EDT  Geron to Host a Virtual Investor Event in November   Business Wire
Oct 12, 2021
08:13AM EDT  The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology   Benzinga
05:47AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.30 A.M. EDT).   RTTNews
Oct 11, 2021
04:44PM EDT  Geron Highlights Publication Of Analyses Comparing Real World Data To IMbark Phase 2 In 'Annals Of Hematology'   Benzinga
04:30PM EDT  Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology   Business Wire
Oct 4, 2021
12:06PM EDT  Geron Earnings Perspective: Return On Capital Employed   Benzinga
Sep 16, 2021
04:30PM EDT  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Sep 1, 2021
04:30PM EDT  Geron Announces September Investor Conference Presentation Webcasts   Business Wire
Aug 19, 2021
04:30PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 16, 2021
04:45PM EDT  Recap: Geron Q2 Earnings   Benzinga
04:09PM EDT  Geron Q2 EPS $(0.09) Misses $(0.08) Estimate, Sales $107.00K Beat $60.00K Estimate   Benzinga
04:06PM EDT  Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023   Business Wire
04:04AM EDT  Earnings Scheduled For August 16, 2021   Benzinga
Aug 10, 2021
02:42PM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Aug 5, 2021
04:30PM EDT  Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021   Business Wire
Jul 22, 2021
04:45PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Jun 24, 2021
09:49AM EDT  Return On Capital Employed Overview: Geron   Benzinga
Jun 18, 2021
03:05PM EDT  Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; CAI International Shares Spike Higher   Benzinga
12:18PM EDT  Mid-Day Market Update: Crude Oil Rises Over 1%; Orphazyme Shares Plunge   Benzinga
07:46AM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Jun 17, 2021
04:30PM EDT  Geron Announces Publication Of IMbark Phase 2 Data In Journal Of Clinical Oncology   Benzinga
Jun 14, 2021
04:30PM EDT  Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress   Business Wire
Jun 8, 2021
11:35AM EDT  Geron: Return On Capital Employed Insights   Benzinga
May 12, 2021
11:06AM EDT  Geron Announces Two Presentations At Upcoming European Hematology Association Annual Congress   RTTNews
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
May 10, 2021
04:47PM EDT  Geron: Q1 Earnings Insights   Benzinga
04:46PM EDT  Geron Q1 EPS $(0.09) Misses $(0.08) Estimate, Sales $137.00K Beat $50.00K Estimate   Benzinga
04:11PM EDT  Geron Q1 Loss/Shr $0.09 Vs Loss $0.08 Last Year   RTTNews
04:06PM EDT  Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights   Business Wire
04:09AM EDT  Earnings Scheduled For May 10, 2021   Benzinga
May 3, 2021
04:30PM EDT  Geron to Announce First Quarter 2021 Financial Results on May 10, 2021   Business Wire
Apr 22, 2021
04:30PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Apr 13, 2021
07:46AM EDT  Biopharmaceutical company Geron Corp. (GERN) announced Tuesday that the first patient has been dosed in IMpactMF, the Phase 3 clinical trial evaluating imetelstat, a first-in-class telomerase inhibitor, in refractory myelofibrosis (MF).   RTTNews
07:35AM EDT  Geron Says First Patient Has Been Dosed In IMpactMF Phase 3 Clinical Trial In Refractory Myelofibrosis   RTTNews
07:31AM EDT  Geron Announces First Patient Dosed In IMpactMF Phase 3 Clinical Trial In Refractory Myelofibrosis   Benzinga
Mar 18, 2021
04:45PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Mar 12, 2021
07:36AM EST  The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs   Benzinga
Mar 11, 2021
04:21PM EST  Geron Corp. Q4 Loss/share $0.07 Vs. Loss $0.15 Year Ago   RTTNews
04:14PM EST  Geron Q4 EPS $(0.07) Misses $(0.06) Estimate, Sales $50.00K Inline   Benzinga
04:10PM EST  Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights   Business Wire
08:19AM EST  The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena   Benzinga
03:35AM EST  Earnings Scheduled For March 11, 2021   Benzinga
Mar 10, 2021
10:08AM EST  Geron's Earnings Outlook   Benzinga
Mar 6, 2021
10:58AM EST  The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings   Benzinga
Mar 1, 2021
04:45PM EST  Geron to Announce Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021   Business Wire
Feb 18, 2021
04:45PM EST  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Jan 14, 2021
04:45PM EST  Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference   Business Wire
Dec 11, 2020
08:35AM EST  Geron Plans For IMpactMF To Evaluate Imetelstat Compared To Best Available Therapy In 320 Patients   RTTNews
08:31AM EST  Geron Announces Opening Of IMpactMF Phase 3 Clinical Trial In Refractory Myelofibrosis   Benzinga
Dec 10, 2020
08:36AM EST  Geron Announces 50% Enrollment Milestone In IMerge Phase 3 Clinical Trial In Lower Risk MDS   Benzinga
08:34AM EST  Geron Reports Achievement Of 50% Enrollment In IMerge Phase 3 Clinical Trial Of Imetelstat In Lower Risk MDS   RTTNews
08:30AM EST  Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS   Business Wire
Dec 7, 2020
07:40PM EST  Geron Says Imetelstat Presentations Provide Strong Support For two Registration-enabling Phase 3 Trials   RTTNews
06:45PM EST  Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting   Business Wire
Nov 19, 2020
04:30PM EST  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Nov 10, 2020
04:30PM EST  Geron to Present at the Stifel Virtual Healthcare Conference   Business Wire
Nov 5, 2020
05:08PM EST  Geron Q3 EPS $(0.06), Inline, Sales $108.00K Beat $40.00K Estimate   Benzinga
04:25PM EST  Recap: Geron Q3 Earnings   Benzinga
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 4, 2020
04:27PM EST  Geron Announces Ten Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting   Business Wire
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 29, 2020
04:30PM EDT  Geron to Announce Third Quarter Financial Results on November 5, 2020   Business Wire
Oct 28, 2020
05:03PM EDT  Geron Announces Publication Of IMerge Phase 2 Data In Journal Of Clinical Oncology   Benzinga
Oct 1, 2020
04:30PM EDT  Geron Reports Secured $75M Loan Facility With Hercules Capital   Benzinga
04:30PM EDT  Geron Secures Loan Facility for Up to $75 Million   Business Wire
Sep 17, 2020
04:30PM EDT  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Sep 9, 2020
09:00AM EDT  Geron to Present at the H.C. Wainwright Global Investment Conference   Business Wire
Aug 26, 2020
08:14AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
06:04AM EDT  HC Wainwright & Co. Maintains Buy on Geron, Raises Price Target to $7   Benzinga
Aug 20, 2020
04:30PM EDT  Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Aug 6, 2020
05:20PM EDT  Geron Q2 EPS $(0.06), Inline, Sales $43.00K Miss $60.00K Estimate   Benzinga
04:28PM EDT  Geron Q2 Loss/Shr $0.06 Vs Loss $$0.08 Last Year   RTTNews
04:06PM EDT  Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events   Business Wire
Aug 4, 2020
04:45PM EDT  Geron to Present at the BTIG Virtual Biotechnology Conference   Business Wire
Aug 3, 2020
09:32AM EDT  Benzinga's Top Upgrades, Downgrades For August 3, 2020   Benzinga
07:42AM EDT  Stifel Initiates Coverage On Geron with Buy Rating   Benzinga
Jul 30, 2020
04:30PM EDT  Geron to Announce Second Quarter Financial Results on August 6, 2020   Business Wire
Jul 16, 2020
08:36AM EDT  Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC